p.44 抽出テキスト

Circulation. 2017;136:e60–e122. DOI: 10.1161/CIR.0000000000000499 August 1, 2017 e103 CLINICAL STATEMENTS AND GUIDELINES

170.	 Boersma L, Mont L, Sionis A, et al. Value of the implantable loop recorder for the management of patients with unexplained syncope. Europace. 2004;6:70–6. 171.	 Krahn AD, Klein GJ, Yee R, et al. Detection of asymptomatic arrhythmias in unexplained syncope. Am Heart J. 2004;148:326–32. 172.	 Pierre B, Fauchier L, Breard G, et al. Implantable loop recorder for recurrent syncope: influence of cardiac conduction abnormalities showing up on resting electrocardiogram and of underlying cardiac disease on follow-up developments. Europace. 2008;10:477–81. 173.	 Edvardsson N, Frykman V, van Mechelen R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. 2011;13:262–9. 174.	 Linker NJ, Voulgaraki D, Garutti C, et al. Early versus delayed implantation of a loop recorder in patients with unexplained syncope—effects on care pathway and diagnostic yield. Int J Cardiol. 2013;170:146–51. 175.	 Palmisano P, Accogli M, Zaccaria M, et al. Predictive factors for pacemaker implantation in patients receiving an implantable loop recorder for syncope remained unexplained after an extensive cardiac and neurological workup. Int J Cardiol. 2013;168:3450–7. 176.	 Podoleanu C, DaCosta A, Defaye P, et al. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French healthcare system (FRESH study). Arch Cardiovasc Dis. 2014;107:546–52. 177.	 Sulke N, Sugihara C, Hong P, et al. The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial. Europace. 2016;18:912–8. 178.	 Solbiati M, Costantino G, Casazza G, et al. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. Cochrane Database Syst Rev. 2016;4:CD011637 179.	 Brignole M, Menozzi C, Maggi R, et al. The usage and diagnostic yield of the implantable loop-recorder in detection of the mechanism of syncope and in guiding effective antiarrhythmic therapy in older people. Europace. 2005;7:273–9. 180.	 Krahn AD, Klein GJ, Fitzpatrick A, et al. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing Clin Electrophysiol. 2002;25:37–41. 181.	 Lombardi F, Calosso E, Mascioli G, et al. Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope. Europace. 2005;7:19–24. 182.	 Benezet-Mazuecos J, Ibanez B, Rubio JM, et al. Utility of in-hospital cardiac remote telemetry in patients with unexplained syncope. Europace. 2007;9:1196–201. 183.	 Lipskis DJ, Dannehl KN, Silverman ME. Value of radiotelemetry in a community hospital. Am J Cardiol. 1984;53:1284–7. 184.	 Kapoor WN. Syncope. N Engl J Med. 2000;343:1856–62. 185.	 Estrada CA, Rosman HS, Prasad NK, et al. Role of telemetry monitoring in the non-intensive care unit. Am J Cardiol. 1995;76:960–5. 186.	 Sivaram CA, Summers JH, Ahmed N. Telemetry outside critical care units: patterns of utilization and influence on management decisions. Clin Cardiol. 1998;21:503–5. 187.	 Ivonye C, Ohuabunwo C, Henriques-Forsythe M, et al. Evaluation of telemetry utilization, policy, and outcomes in an inner-city academic medical center. J Natl Med Assoc. 2010;102:598–604. 188.	 Ungar A, Mussi C, Del Rosso A, et al. Diagnosis and characteristics of syncope in older patients referred to geriatric departments. J Am Geriatr Soc. 2006;54:1531–6. 189.	 Fujimura O, Yee R, Klein GJ, et al. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. N Engl J Med. 1989;321:1703–7. 190.	 Scheinman MM, Peters RW, Suavé MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 1982;50:1316–22. 191.	 Blanc JJ. Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation? Prog Cardiovasc Dis. 2013;55:418–24. 192.	 Link MS, Kim KM, Homoud MK, et al. Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation. Am J Cardiol. 1999;83:1334–7. 193.	 Militianu A, Salacata A, Seibert K, et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol. 1997;8:1087–97. 194.	 Pezawas T, Stix G, Kastner J, et al. Unexplained syncope in patients with

structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantable cardioverter defibrillator therapy. Europace. 2003;5:305–12. 195.	 Steinberg JS, Beckman K, Greene HL, et al. Follow-up of patients

with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001;12:996–1001. 196.	 Andrews NP, Fogel RI, Pelargonio G, et al. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol. 1999;34:2023–30. 197.	 Bass EB, Elson JJ, Fogoros RN, et al. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol. 1988;62:1186–91. 198.	 Olshansky B, Mazuz M, Martins JB. Significance of inducible tachycardia in patients with syncope of unknown origin: a long-term follow-up. J Am Coll Cardiol. 1985;5:216–23. 199.	 Denniss AR, Ross DL, Richards DA, et al. Electrophysiologic studies in patients with unexplained syncope. Int J Cardiol. 1992;35:211–7. 200.	 Lacroix D, Dubuc M, Kus T, et al. Evaluation of arrhythmic causes of syncope: correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping. Am Heart J. 1991;122:1346–54. 201.	 Sra JS, Anderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med. 1991;114:1013–9. 202.	 Click RL, Gersh BJ, Sugrue DD, et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol. 1987;59:817–23. 203.	 Reiffel JA, Wang P, Bower R, et al. Electrophysiologic testing in patients with recurrent syncope: are results predicted by prior ambulatory monitoring? Am Heart J. 1985;110:1146–53. 204.	 Morady F, Higgins J, Peters RW, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol. 1984;54:587–91. 205.	 Gulamhusein S, Naccarelli GV, Ko PT, et al. Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med. 1982;73:700–5. 206.	 Sagristà-Sauleda J, Romero-Ferrer B, Moya A, et al. Variations in diagnostic yield of head-up tilt test and electrophysiology in groups of patients with syncope of unknown origin. Eur Heart J. 2001;22:857–65. 207.	 Gatzoulis KA, Karystinos G, Gialernios T, et al. Correlation of noninvasive electrocardiography with invasive electrophysiology in syncope of unknown origin: implications from a large syncope database. Ann Noninvasive Electrocardiol. 2009;14:119–27. 208.	 Kenny RA, Ingram A, Bayliss J, et al. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;1:1352–5. 209.	 Fitzpatrick A, Theodorakis G, Vardas P, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J. 1991;12:389–94. 210.	 Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989;320:346–51. 211.	 Grubb BP, Kosinski D. Tilt table testing: concepts and limitations. Pacing Clin Electrophysiol. 1997;20:781–7. 212.	 Morillo CA, Klein GJ, Zandri S, et al. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J. 1995;129:901–6. 213.	 Natale A, Akhtar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation. 1995;92:54–8. 214.	 Brignole M, Menozzi C, Del Rosso A, et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace. 2000;2:66–76. 215.	 Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol. 1996;28:263–75. 216.	 Gisolf J, Westerhof BE, van DN, et al. Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response. J Am Coll Cardiol. 2004;44:588–93. 217.	 Raviele A, Menozzi C, Brignole M, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol. 1995;76:267–72. 218.	 Gibbons CH, Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology. 2006;67:28–32. 219.	 Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hy-

potension: a 10-year follow-up study. Neurology. 2015;85:1362–7.

Downloaded from http://ahajournals.org by on October 7, 2026